CLINUVEL (ASX:CUV) Completes Phase III Vitiligo Trial Recruitment
CLINUVEL (ASX:CUV) completes recruitment for its Phase III vitiligo trial, with initial results expected in the second half of 2026.
Tag: Regulatory News & Compliance
NAB Limited (ASX:NAB) Reports Strong 1H25 Financial Performance
NAB Limited (ASX:NAB) reports increased cash earnings and strong capital ratios for the first half of 2025.
Reliance Worldwide Corporation Limited (ASX:RWC) Updates on US Tariffs and FY25 Trading Outlook
Reliance Worldwide Corporation Limited (ASX:RWC) implements strategies to mitigate US tariffs and updates its FY25 trading outlook.
Helia Group Limited (ASX:HLI) Releases 1Q25 APRA Lodgement and Trading Update
Helia Group Limited (ASX:HLI) announces its 1Q25 financial results and updates on trading performance and strategic responses to policy changes.
Nyrada Inc (ASX:NYR) Advances Phase I Clinical Trial to Third Cohort
Nyrada Inc (ASX:NYR) progresses its Phase I clinical trial to the third cohort, with final readouts expected in Q3 2025.
ONCOSIL MEDICAL LTD (ASX:OSL) Announces Security Consolidation
ONCOSIL MEDICAL LTD (ASX:OSL) announces a 400-to-1 security consolidation, outlining the consolidation ratio, timetable, and impact on securities.
Dimerix Limited (ASX:DXB) Secures Major Licensing Deal in Japan and FDA Endorsement for DMX-200
Dimerix Limited (ASX:DXB) secures a ¥10.5 billion licensing deal in Japan and receives FDA endorsement for its DMX-200 therapy.
EMVision Medical Devices Limited (ASX:EMV) Launches Clinical Trial for emu™ Device
EMVision Medical Devices Limited (ASX:EMV) has commenced pivotal clinical trials for its emu™ brain scanner and announced successful device testing and robust cash reserves.
Bubs Australia Limited (ASX:BUB) Wins Arbitration Awards
Bubs Australia Limited (ASX:BUB) secures $22.9M and $3.6M arbitration awards against Alpha Group subsidiaries.
Health and Plant Protein Group Limited (ASX:HPP) Releases FY25 Q3 Activities Report
Health and Plant Protein Group Limited (ASX:HPP) releases FY25 Q3 report, highlighting cash flow and ongoing IRS repayment efforts.